Vivek Ramaswamy (Paul Sancya/AP Images)
August 21, 2023 11:21 AM EDTUpdated 02:10 PM
People
Law

Ex-em­ploy­ees of Ra­maswamy's in­vest­ment com­pa­ny sue, claim­ing they were mis­led or pushed to vi­o­late se­cu­ri­ties law

Zachary Brennan

Senior Editor

Re­pub­li­can pres­i­den­tial can­di­date and for­mer biotech CEO Vivek Ra­maswamy, and the an­ti-ESG as­set man­age­ment com­pa­ny he co-found­ed, were sued in re­cent months by two for­mer …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Pfiz­er look­ing to sell hos­pi­tal drugs unit — re­ports

'Ex­per­tise is a re­al thing': FDA com­mis­sion­er warns of po­lit­i­cal risk to agency

As­traZeneca CEO reaf­firms com­mit­ment to Chi­na fol­low­ing ex­ec­u­tive's de­ten­tion

Mer­ck, As­traZeneca tout Phase 3 win for can­cer-turned-rare dis­ease drug

Sanofi, Ope­nAI, For­ma­tion Bio de­but pa­tient re­cruit­ing tool, will use in Phase 3 mul­ti­ple scle­ro­sis stud­ies

sponsored

What Will It Take to Re­verse Fi­bro­sis in Pa­tients with Ad­vanced MASH?

A service from the Financial Times